dear
editor
zika
viru
zikv
pathogen
within
genu
flaviviru
famili
flavivirida
brought
intern
public
health
emerg
due
associ
neonat
microcephali
case
platt
miner
current
reliabl
diagnost
test
pcr
detect
zikv
rna
bodi
fluid
sampl
unfortun
short
viremia
window
asymptomaticmild
infect
greatli
reduc
success
rate
pcr
de
vasconcelo
et
al
serolog
assay
play
pivot
role
retrospect
diagnosi
zikv
infect
especi
pregnant
women
concern
zikv
infect
earli
stage
pregnanc
de
vasconcelo
et
al
howev
due
high
level
cross
reactiv
among
relat
flavivirus
serolog
test
conduct
locat
flavivirus
cocircul
prove
difficult
make
conclus
diagnosi
especi
diagnosi
zikv
infect
dengu
viru
denv
preexpos
individu
david
et
al
lhuillier
et
al
de
vasconcelo
et
al
difficulti
exacerb
lack
serum
panel
individu
absolut
defin
infect
statu
henc
present
chickenandegg
cycl
attempt
develop
specif
assay
reli
serum
panel
infect
statu
defin
case
even
gold
standard
assay
viru
neutral
test
vnt
inconclus
zikv
denv
antibodi
known
crossneutr
collin
et
al
address
challeng
produc
panel
monkey
sera
cover
four
infect
scenario
zikv
alon
group
z
denv
alon
zikv
follow
denv
zd
denv
follow
zikv
dz
dose
pfu
zikvbrazil
genbank
id
andor
genbank
id
use
subcutan
inocul
cynomolgu
macaqu
macaca
fasciculari
anim
per
group
infect
studi
approv
institut
anim
care
use
committe
singhealth
experiment
medicin
centr
absenc
zikv
denv
antibodi
anim
confirm
use
commerci
elisa
kit
zika
antizika
viru
elisa
igg
euroimmun
denv
panbio
dengu
igg
indirect
elisa
abbott
respect
day
post
infect
dpi
seroconvers
evid
z
group
respect
data
shown
anim
challeng
viru
use
dose
primari
infect
bled
day
postsecondari
infect
fig
fig
previous
report
david
et
al
lhuillier
et
al
signific
cross
reactiv
two
virus
observ
use
commerci
elisa
kit
improv
specif
develop
multiplex
luminex
assay
similar
previous
publish
recombin
e
protein
zikv
respect
obtain
nativ
antigen
compani
uk
lg
protein
coupl
magplex
bead
magplexc
microspher
lg
bead
use
xmap
antibodi
coupl
kit
obtain
luminex
usa
follow
manufactur
protocol
shown
fig
antibodi
group
z
cross
react
denv
ratio
zd
greater
either
e
protein
true
three
anim
group
similarli
dz
ratio
greater
three
anim
group
fig
anoth
word
singl
viru
infect
group
either
z
ratiobas
luminex
readout
suffici
specif
differenti
zika
dengu
infect
see
supplementari
figur
tabl
origin
data
show
luminex
read
either
e
antigen
statist
differ
primari
infect
two
virus
howev
group
zd
dz
zd
dz
ratio
mostli
indistinguish
therefor
imposs
deduc
viru
respons
recent
infect
assess
cross
reactiv
serum
panel
conduct
plaqu
reduct
neutral
test
prnt
use
previous
publish
method
et
al
result
fig
fig
indic
anim
primari
infect
neutral
observ
homolog
virusserum
pair
howev
mix
infect
group
clear
rule
observ
zd
group
seem
higher
titer
secondari
infect
viru
wherea
dz
group
opposit
higher
titer
primari
infect
viru
secondari
flavivir
infect
well
document
anamnest
antibodi
respons
often
occur
degre
specif
relat
two
virus
vari
guzman
et
al
priyamvada
et
al
bardina
et
al
find
somewhat
limit
due
small
number
anim
use
studi
follow
import
conclus
drawn
studi
signific
cross
reactiv
antizikv
denv
antibodi
singl
virusantigenbas
assay
wo
nt
reliabl
conclus
serodiagnosi
although
sampl
show
antizikv
antibodi
crossreact
denv
vice
versa
overal
twoway
crossreact
level
similar
even
small
number
use
studi
clear
individualto
individu
variat
context
cross
reaction
ratiobas
readout
multiplex
platform
e
luminex
assay
seem
suffici
specif
diagnosi
primari
infect
singl
viru
current
test
platform
even
gold
standard
prnt
abl
determin
recent
secondari
infect
might
therefor
worthwhil
look
develop
epitopespecif
test
could
potenti
detect
zikvspecif
antibodi
presenc
antidenv
antibodi
monoclon
antibodybas
block
elisa
balmaseda
et
al
peptid
array
jelsma
et
al
peptid
display
phage
librari
xu
et
al
approach
deploy
address
challeng
issu
need
urgent
solut
caution
epitopebas
serolog
prone
subtl
immun
respons
differ
individu
multiplex
approach
includ
multipl
virusspecif
epitop
may
deploy
conflict
interest
author
declar
conflict
interest
